Non-small cell lung cancer in the new millennium: The effect of FDG-PET on stage distribution.

被引：0
|
作者：
Goodgame, B.
Morgensztern, D.
Grove, L.
Govindan, R.
机构：
[1] Barnes Jewish Hosp, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7205
引用
收藏
页码：415S / 415S
页数：1
相关论文
共 50 条
  • [41] FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer
    Hoopes, David J.
    Tann, Mark
    Fletcher, James W.
    Forquer, Jeffrey A.
    Lin, Pei-Fen
    Lo, Simon S.
    Timmerman, Robert D.
    McGarry, Ronald C.
    LUNG CANCER, 2007, 56 (02) : 229 - 234
  • [42] The value of FDG PET/CT to stage non-small cell lung cancer: Ankara University experience
    Kucuk, O.
    Lacin, S.
    Soylu, M.
    Aras, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S333 - S333
  • [43] Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease
    Farrell, MA
    McAdams, HP
    Herndon, JE
    Patz, EF
    RADIOLOGY, 2000, 215 (03) : 886 - 890
  • [44] FDG-PET/CT Imaging for Mediastinal Staging in Patients With Potentially Resectable Non-Small Cell Lung Cancer
    Schmidt-Hansen, Mia
    Baldwin, David Raymond
    Zamora, Javier
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (14): : 1465 - 1466
  • [45] FDG-PET metrics in advanced non-small cell lung cancer (NSCLC): a review and meta-analysis
    Aviva C. Berkowitz
    Balazs Halmos
    Haiying Cheng
    Cal Huntzinger
    Nitin Ohri
    Clinical and Translational Imaging, 2023, 11 : 381 - 387
  • [46] Correlation of FDG-PET findings with histopathology in the assessment of response to induction chemoradiotherapy in non-small cell lung cancer
    Yuka Yamamoto
    Yoshihiro Nishiyama
    Toshihide Monden
    Yasuhiro Sasakawa
    Motoomi Ohkawa
    Masashi Gotoh
    Kotaro Kameyama
    Reiji Haba
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 140 - 147
  • [47] Mid-treatment FDG-PET predicts disease progression in patients with non-small cell lung cancer
    Olson, M. R.
    Weerasuriya, D. K.
    Wakelee, H. A.
    Quon, A.
    Maxim, P. G.
    Le, Q.
    Graves, E. E.
    Loo, B. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S504 - S504
  • [48] The role of FDG-PET/CT in detecting unsuspected distant metastasis in the staging of non-small cell lung cancer
    Ozhan, M.
    Halac, M.
    Aliyev, A.
    Yilmaz, S.
    Sager, S.
    Ergul, N.
    Sonmezoglu, K.
    Uslu, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S360 - S360
  • [49] TIGAR is correlated with maximal standardized uptake value on FDG-PET and survival in non-small cell lung cancer
    Zhou, Xiang
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [50] Correlation of FDG-PET findings with histopathology in the assessment of response to induction chemoradiotherapy in non-small cell lung cancer
    Yamamoto, Y
    Nishiyama, Y
    Monden, T
    Sasakawa, Y
    Ohkawa, M
    Gotoh, M
    Kameyama, K
    Haba, R
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (02) : 140 - 147
12345